Những thông tin về SARS-COV-2 hiện nay (ngày 11/3 - 18/3/2022)

Thứ sáu - 18/03/2022 01:03
|In ra
|Đóng cửa sổ này

Cục Thông tin khoa học và công nghệ quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu về SARS-COV-2 hiện nay. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.

SCIENCEDIRECT

1. Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: Genetic relations and vaccine strain match

Virus Research, 21 January 2022, Volume 311 (Cover date: 2 April 2022), Article 198688

Paula Perbolianachis, Diego Ferla, Juan Cristina
https://www.sciencedirect.com/science/article/pii/S0168170222000168/pdfft?md5=0c32e50788d6879f6827298509e09054&pid=1-s2.0-S0168170222000168-main.pdf

2. A systematic review on SARS-CoV-2 remission: an emerging challenge for its management, treatment, immunization strategies, and post-treatment guidelines

New Microbes and New Infections, 7 January 2022, Volume 45 (Cover date: January 2022), Article 100949

R. Joshi, R. Singla, B. Medhi

https://www.sciencedirect.com/science/article/pii/S2052297522000014/pdfft?md5=3151bad827fccbd0c19019393042b507&pid=1-s2.0-S2052297522000014-main.pdf

3. Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics

Gene Reports, 2 February 2022, Volume 26 (Cover date: March 2022), Article 101537

Abozar Ghorbani, Samira Samarfard, Keramatollah Izadpanah

https://www.sciencedirect.com/science/article/pii/S2452014422000450/pdfft?md5=cd986d0e656c53398819813379b175de&pid=1-s2.0-S2452014422000450-main.pdf

4. Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients
Human Immunology, 4 November 2021, Volume 83, Issue 2 (Cover date: February 2022), Pages 119-129

Haitao Xiang, Yingze Zhao, Penghui Yang

https://www.sciencedirect.com/science/article/pii/S0198885921002524/pdfft?md5=6369706a9b5696c17ea06d5c11592ab5&pid=1-s2.0-S0198885921002524-main.pdf

5. Therapeutics for COVID-19 and post COVID-19 complications: An update

Current Research in Pharmacology and Drug Discovery, Available online 4 February 2022 In press, journal pre-proof, Article 100086

Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
https://www.sciencedirect.com/science/article/pii/S2590257122000062/pdfft?md5=b5f3cbf17e00ca66fa356c7044406ca3&pid=1-s2.0-S2590257122000062-main.pdf

6. Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review

Journal of Virological Methods, 24 November 2021, Volume 300 (Cover date: February 2022), Article 114375

Fatima Akram, Ikram ul Haq, Rukhma Sattar

https://www.sciencedirect.com/science/article/pii/S0166093421003141/pdfft?md5=74bb68ab9f0bd081451e01ac648b30ad&pid=1-s2.0-S0166093421003141-main.pdf

7. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis

American Journal of Kidney Diseases, 8 September 2021, Volume 79, Issue 2 (Cover date: February 2022), Pages 185-192.e1

Ilias Bensouna, Valérie Caudwell, Pierre Housset
https://www.sciencedirect.com/science/article/abs/pii/S0272638621008337

8. Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab

Multiple Sclerosis and Related Disorders, 9 November 2021, Volume 57 (Cover date: January 2022), Article 103382

J. D. Katz, A. J. Bouley, E. S. Lathi

https://www.sciencedirect.com/science/article/pii/S2211034821006490/pdfft?md5=fb2e1a05a1e62ad68f5eab6e2b27c1ba&pid=1-s2.0-S2211034821006490-main.pdf

9. Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia

Infection, Genetics and Evolution, 18 December 2021, Volume 97 (Cover date: January 2022), Article 105192

Jubby Marcela Gálvez, Henry Mauricio Chaparro-Solano, Ángela María Ruiz-Sternberg

https://www.sciencedirect.com/science/article/pii/S1567134821004925/pdfft?md5=163307288831f4d73a4fe911eeed05d6&pid=1-s2.0-S1567134821004925-main.pdf

10. Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery
Journal of Infection and Public Health, 19 January 2022, Volume 15, Issue 2 (Cover date: February 2022), Pages 289-296

Sali Abubaker Bagabir, Nahla Khamis Ibrahim, Raghdah Hashem Ateeq

https://www.sciencedirect.com/science/article/pii/S1876034122000144/pdfft?md5=0480ce1be0d26cb7a5171926f52941bd&pid=1-s2.0-S1876034122000144-main.pdf

11. Plasmonic-Magnetic Nanorobots for SARS-CoV-2 RNA Detection through Electronic Readout
Applied Materials Today, Available online 7 February 2022 In press, journal pre-proof, Article 101402

Jeonghyo Kim, Carmen C. Mayorga-Martinez, Martin Pumera

https://www.sciencedirect.com/science/article/pii/S2352940722000415/pdfft?md5=10f4093ab1efe331ecdb37549da54755&pid=1-s2.0-S2352940722000415-main.pdf

12. Identification of potent small molecule inhibitors of SARS-CoV-2 entry

SLAS Discovery, 25 October 2021, Volume 27, Issue 1 (Cover date: January 2022), Pages 8-19

Sonia Mediouni, Huihui Mou, Timothy P. Spicer

https://www.sciencedirect.com/science/article/pii/S2472555221000125/pdfft?md5=9afab5e144d8dd342ae4a6cf01625c83&pid=1-s2.0-S2472555221000125-main.pdf

13. Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors

Molecular Therapy, Available online 14 January 2022 In press, corrected proof

Jonas Becker, Megan Lynn Stanifer, Dirk Grimm

https://www.sciencedirect.com/science/article/pii/S1525001622000247/pdfft?md5=d0306679e608f46a755f96902f5fd63b&pid=1-s2.0-S1525001622000247-main.pdf

14. Tracking and controlling the spatiotemporal spread of SARS-CoV-2 Omicron variant in South Africa

Travel Medicine and Infectious Disease, 30 December 2021, Volume 46 (Cover date: March–April 2022), Article 102252

Chengzhuo Tong, Wenzhong Shi, Zhicheng Shi

https://www.sciencedirect.com/science/article/pii/S1477893921002933/pdfft?md5=63329abf58fbaa5c0be254ec9909ae53&pid=1-s2.0-S1477893921002933-main.pdf

15. Myocarditis following mRNA Covid-19 vaccination: a pooled analysis

Vaccine, Available online 7 February 2022 In press, journal pre-proof

Ioannis Bellos, Vasilios Karageorgiou, Dana Viskin

https://www.sciencedirect.com/science/article/pii/S0264410X22001402/pdfft?md5=e1bc7cb9b4106147cc295c7e1900b36a&pid=1-s2.0-S0264410X22001402-main.pdf

16. SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis

Informatics in Medicine Unlocked, 4 February 2022, Volume 29 (Cover date: 2022), Article 100873

Ibrahim Khater, Aaya Nassar

https://www.sciencedirect.com/science/article/pii/S2352914822000272/pdfft?md5=3056f8f098cae4e5395339322534b9e8&pid=1-s2.0-S2352914822000272-main.pdf

SPRINGER NATURE

1. COVID-19 Vaccination for Frail Older Adults in Singapore - Rapid Evidence Summary and Delphi Consensus Statements

J. Gao, P. Lun, Y. Y. Ding, Pradeep Paul George in The Journal of Frailty & Aging (2022)

https://link.springer.com/content/pdf/10.14283%2Fjfa.2022.12.pdf

2. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform

Nawamin Sa-nguanmoo, Katawut Namdee, Mattaka Khongkow, Uracha Ruktanonchai… in Nano Research (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12274-021-3832-y.pdf

3. COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity

Mi-Hyun Lee, Bum-Joon Kim in Journal of Microbiology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12275-022-1621-2.pdf

4. Practice report: an Alberta Métis model for COVID-19 vaccine delivery

Keith D. King, Reagan Bartel, Ashton James… in Canadian Journal of Public Health (2022)

https://link.springer.com/content/pdf/10.17269%2Fs41997-021-00603-7.pdf

5. Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients

Michael Haase, Paul Lesny, Mark Anderson, Gavin Cloherty… in Journal of Nephrology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40620-022-01247-7.pdf

6. Facilitators and barriers to compliance with COVID-19 guidelines: a structural topic modelling analysis of free-text data from 17,500 UK adults

Liam Wright, Elise Paul, Andrew Steptoe, Daisy Fancourt in BMC Public Health (2022)

https://link.springer.com/content/pdf/10.1186%2Fs12889-021-12372-6.pdf

7. Study of the epidemiology of COVID-19 in Ontario elementary and secondary school education workers: an interim analysis following the first school year

Brenda L. Coleman, Kailey Fischer, Robert Maunder… in Canadian Journal of Public Health (2022)

https://link.springer.com/content/pdf/10.17269%2Fs41997-022-00613-z.pdf

8. A Modern Perspective on Vaccinating Healthcare Service Providers in India: A Narrative Review

Mallavalli Surendranath, Ravi Wankhedkar, Jayesh Lele… in Infectious Diseases and Therapy (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40121-021-00558-9.pdf

9. Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies

Jung-ah Choi, Jae-Ouk Kim in Journal of Microbiology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12275-022-1547-8.pdf

10. Global research activity on mathematical modeling of transmission and control of 23 selected infectious disease outbreak

Waleed M. Sweileh in Globalization and Health (2022)

https://link.springer.com/content/pdf/10.1186%2Fs12992-022-00803-x.pdf

PUBMED

1. Innovations and development of Covid-19 vaccines: A patent review.

Alshrari AS, Hudu SA, Imran M, Asdaq SMB, Ali AM, Rabbani SI.

J Infect Public Health. 2022 Jan;15(1):123-131. doi: 10.1016/j.jiph.2021.10.021. Epub 2021 Oct 23.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539827/pdf/main.pdf

2. Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening.

Tande AJ, Pollock BD, Shah ND, Farrugia G, Virk A, Swift M, Breeher L, Binnicker M, Berbari EF.

Clin Infect Dis. 2022 Jan 7;74(1):59-65. doi: 10.1093/cid/ciab229.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989519/pdf/ciab229.pdf

3. COVID-19 vaccines and skin manifestations.

Bataille V, Puig S.

Br J Dermatol. 2022 Jan;186(1):15. doi: 10.1111/bjd.20807. Epub 2021 Nov 2.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653104/pdf/BJD-9999-0.pdf

4. COVID-19 mRNA Vaccine-induced Pneumonitis.

Matsuzaki S, Kamiya H, Inoshima I, Hirasawa Y, Tago O, Arai M.

Intern Med. 2022 Jan 1;61(1):81-86. doi: 10.2169/internalmedicine.8310-21. Epub 2021 Oct 26.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810239/pdf/1349-7235-61-0081.pdf

5. COVID-19 testing demand amidst Omicron variant surge: Mass hysteria or population health need?

Bhagavathula AS, Massey PM, Khubchandani J.

Brain Behav Immun. 2022 Mar;101:394-396. doi: 10.1016/j.bbi.2022.01.023. Epub 2022 Feb 2.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809661/pdf/main.pdf

6. Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression.

Pardamean E, Roan W, Iskandar KTA, Prayangga R, Hariyanto TI.

Gen Hosp Psychiatry. 2022 Mar-Apr;75:61-67. doi: 10.1016/j.genhosppsych.2022.01.010. Epub 2022 Feb 4.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813760/pdf/main.pdf

7. Biosensors for the Determination of SARS-CoV-2 Virus and Diagnosis of COVID-19 Infection.

Drobysh M, Ramanaviciene A, Viter R, Chen CF, Samukaite-Bubniene U, Ratautaite V, Ramanavicius A.

Int J Mol Sci. 2022 Jan 8;23(2):666. doi: 10.3390/ijms23020666.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776074/pdf/ijms-23-00666.pdf

8. Identifying COVID-19 Infections From a Vaccinated Population Using Specific IgA Antibody Test.

Cheng ZJ, Zheng P, Xue M, Chen Y, Sun B.

Front Immunol. 2022 Jan 31;13:821218. doi: 10.3389/fimmu.2022.821218. eCollection 2022.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841746/pdf/fimmu-13-821218.pdf

9. Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva.

Kou S, Kile S, Kambampati SS, Brady EC, Wallace H, De Sousa CM, Cheung K, Dickey L, Wentworth KL, Hsiao EC.

Orphanet J Rare Dis. 2022 Mar 4;17(1):107. doi: 10.1186/s13023-022-02246-4.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894823/pdf/13023_2022_Article_2246.pdf

10. Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis

Gil-Díaz A, Gil-Hernández A, Lozano-Jiménez AI, Benítez-Peña J, Conde-Martel A.

Thromb Res. 2022 Jan; 209:84-85. doi: 10.1016/j.thromres.2021.12.004. Epub 2021 Dec 8.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651485/pdf/main.pdf

WILEY

1. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis

Adithan Ganesh, Michael D. Randall

First published: 04 February 2022

https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.15258

2. Modeling the factors that influence exposure to SARS-CoV-2 on a subway train carriage

Daniel Miller, Marco-Felipe King, James Nally, Joseph R. Drodge, Gary I. Reeves, Andrew M. Bate, Henry Cooper, Ursula Dalrymple, Ian Hall, Martín López-García, Simon T. Parker, Catherine J. Noakes

First published: 08 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ina.12976

3. Direct inactivation of SARS-CoV-2 by low level Blue Photobiomodulation LED at 470, 454 and 450 nm

Luisa Zupin, Rossella Gratton, Margherita Milani, Libera Clemente, Francesco Fontana, Maurizio Ruscio, Sergio Crovella

First published: 06 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jbio.202100375

4. SARS‐CoV‐2 and mitochondrial proteins in neural‐derived exosomes of COVID‐19

Michael J. Peluso MD, Steven G. Deeks MD, Maja Mustapic PhD, Dimitrios Kapogiannis MD, Timothy J. Henrich MD, Scott Lu MBBS, Sarah A. Goldberg BA, Rebecca Hoh MS, Jessica Chen, Enrique O. Martinez BA, J. Daniel Kelly MD, PhD, Jeffrey N. Martin MD, Edward J. Goetzl MD

Annals of Neurology

First published: 13 March 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ana.26350

5. Impact of COVID‐19 pandemic on patients with obstructing urinary stones complicated by infection

Haim Herzberg, Ziv Savin, Rinat Lasmanovich, Ron Marom, Reuben Ben-David, Roy Mano, Ofer Yossepowitch, Mario Sofer

BJUI Compass

First published: 13 March 2022

https://bjui-journals.onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.145

6. Toxic Epidermal Necrolysis associated with COVID‐19 infection: A case report

Lamia Jouhar, Marva Yahya, Sohair Elsiddiq

Clinical Case Reports

First published: 13 March 2022